Home › Medulloblastoma › Kentucky
Medulloblastoma clinical trials in Kentucky
3 studies for Medulloblastoma are looking for participants at sites in Kentucky.
Digoxin Medulloblastoma Study
- University of Kentucky, Lexington
RecruitingPhase 2
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Norton Children's Hospital, Louisville
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Kentucky Children's Hospital, Lexington
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RecruitingPhase 2
Up to age 21 · All sexes · Updated Aug 12, 2026 · NCT04696029From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.